Prospective Study
Copyright ©The Author(s) 2018.
World J Clin Cases. Dec 6, 2018; 6(15): 952-960
Published online Dec 6, 2018. doi: 10.12998/wjcc.v6.i15.952
Figure 3
Figure 3 Kaplan–Meier plots for relapse-free survival and exacerbation-free survival. A: Kaplan–Meier plots for relapse-free survival; B: Kaplan–Meier plots for exacerbation-free survival. The relapse-free survival rate was significantly higher in Mayo endoscopic subscore (MES) 0, 1 than in MES 2, 3 (P < 0.05; log-rank test), and in Ulcerative Colitis Endoscopic Index of Severity (UCEIS) 0-3 than in UCEIS 4-8 (P < 0.05; log-rank test). Furthermore, the exacerbation-free survival rate was significantly higher in MES 0, 1 than in MES 2, 3 (P < 0.01; log-rank test), and in UCEIS 0-3 than in UCEIS 4-8 (P < 0.01; log-rank test). However, there was no significant difference between clinical activity index (CAI) 0 and CAI 1-4 groups for both survival rates. MES: Mayo endoscopic subscore; CAI: Clinical activity index; UCEIS: Ulcerative Colitis Endoscopic Index of Severity.